Abstract
The neglected tropical disease leishmaniasis, caused by Leishmania spp., is becoming more problematic due to the emergence of drug-resistant strains. Therefore, new drugs to treat leishmaniasis, with novel mechanisms of action, are urgently required. Strathclyde minor groove binders (S-MGBs) are an emerging class of anti-infective agent that have been shown to have potent activity against various bacteria, viruses, fungi and parasites. Herein, it is shown that S-MGBs have potent activity against L. donovani, and that an N-oxide derivation of the tertiary amine tail of typical S-MGBs leads to selective anti-leishmanial activity. Additionally, using S-MGB-219, the N-oxide derivation is shown to retain strong binding to DNA as a 2:1 dimer. These findings support the further study of anti-leishmanial S-MGBs as novel therapeutics.
Original language | English |
---|---|
Article number | 11912 |
Number of pages | 16 |
Journal | International Journal of Molecular Sciences |
Volume | 23 |
Issue number | 19 |
Early online date | 7 Oct 2022 |
DOIs | |
Publication status | Published - 7 Oct 2022 |
Funding
This work was, in part, supported by an EPSTC DTP award to the University of Strathclyde, EP/T517938/1 (2432483), and by a Wellcome Trust Seed Award awarded to F.J.S. (210103/A/18/Z). R.B. was supported by a UKRI FLF (MR/T020970/1).
Keywords
- leishmaniasis
- minor groove binders
- S-MGB
- DNA